Patent valuation services produce a number. Whether that number is worth anything depends on whether you can see how it was reached.

Three approaches underlie all of them — cost, market and income — and income dominates for patents.

The inputs are judgements, not measurements. Royalty rate, revenue base, discount rate, useful life.

A report that does not state those cannot be checked by anyone, and that is the single most useful test to apply before commissioning one.

What you are commissioning

Output Purpose
An indication Internal decision
A full report Transaction or financing
An expert report Litigation
A portfolio review Strategy

Price and rigour scale with purpose. Ask what standard the report is prepared to before comparing quotes.

The test to apply

Can you see the assumptions? If not, the number cannot be checked by you or by anyone you show it to.

The three approaches

Approach Asks Fit for patents
Income What future benefit does it produce? Dominant
Market What have comparable assets sold for? Where comparables exist
Cost What did it take to create or replace? Weak

Cost is weak because prosecution spend says nothing about coverage. Money spent on office actions reflects how hard the examiner was, not what the claims reach.

Market suffers from thin data. Most patent transactions are private and disclosed deals frequently bundle assets.

Cost approach, and why it misleads

Input What it reflects
Prosecution spend How hard the examiner was
Number of office actions Difficulty, not scope
Drafting cost Complexity of description
None of it What the claims cover

Income methods

Method Detail
Relief from royalty What you would pay to license it if you did not own it
Excess earnings Earnings above a business without it
Incremental cash flow The difference the asset makes
Cost savings Where it reduces expense rather than raising revenue

Relief from royalty is the most portable and it reduces the whole question to two numbers — a rate and a base.

Both are contested. The same rate applied to a component or a finished product can differ by more than an order of magnitude. See patent royalty rates.

Before commissioning anything

Free check Time
In force? 3 min
Who owns it? 5 min
Remaining term from the earliest parent 5 min
Any encumbrances recorded 5 min

A valuation of a lapsed patent is a wasted fee.

Who provides valuations

Provider Typical use
Specialist IP valuation firms Transactions, financing
Accounting firms Tax and reporting
Some brokers Pre-sale indication
Expert witnesses Litigation

What a usable report contains

Element Why
Method used, and why Different methods suit different assets
Royalty rate assumed, and its basis The core input
Revenue base, and why that base Moves the answer most
Discount rate Compounds over the horizon
Useful life Remaining term, adjusted
Maintenance costs subtracted A buyer inherits them
Stated limitations What could not be verified
Status and ownership verified Or explicitly assumed

"Stated limitations" is the mark of a serious report. One presenting a figure without saying what it could not confirm is presenting confidence rather than analysis.

Where the variance comes from

Input Effect of a small change
Royalty rate Proportional
Revenue base Proportional — and contested hardest
Discount rate Compounds over the horizon
Useful life Truncates or extends everything
Probability adjustments Multiplies through

Two defensible valuations of the same patent can differ enormously. That is not a failure of the discipline; it is what happens when four judgements multiply.

Which is why stated assumptions matter more than the headline figure.

What actually drives value

Driver Weight
Claims read on products in the market Highest
Documented evidence of that Very high
Remaining term High
Clean recorded ownership Blocking if absent
Family depth and jurisdictions High
Validity robustness High
Prosecution spend Low
Patent count Low

A documented claim chart against a shipping product is the largest single factor. A patent with one is a different asset from a patent without one. See claim chart example.

Ownership defects are blocking rather than discounting. Buyers do not negotiate around a broken chain; they walk.

Foreign members add cost, not just value

US only Multi-jurisdiction
Renewal events 3 per patent Annual per country
Carrying cost Bounded Escalating
Diligence One chain Per jurisdiction

Subtract what a buyer inherits

Fee Due after grant Large Small Micro
First 3.5 years $2,150 $860 $430
Second 7.5 years $4,040 $1,616 $808
Third 11.5 years $8,280 $3,312 $1,656
Total $14,470 $5,788 $2,894

Foreign annuities add more, annually and escalating. A valuation ignoring the carrying cost overstates what anyone would pay.

Ranges beat point estimates

Output Assessment
A single figure Overstates precision
A range with drivers Honest
Scenarios Better still
Sensitivity to base and rate Most informative

Remaining term drives decay

Remaining term Effect
12+ years Full income horizon
8–11 years Strong
5–7 years Meaningfully reduced
Under 3 years Most buyers decline outright
Expired Zero

The decay is not linear. Below roughly three years many buyers will not transact regardless of the claims, because assertion and licensing both take time.

Calculate term from the earliest parent, never the filing date shown. Continuation chains routinely make a patent shorter than it looks.

Portfolio versus single asset

Single patent Portfolio
Method Direct income or market Aggregate, with segmentation
Diligence burden Low Per family
Blended figure Not applicable Hides where value sits
Reporting One figure Components, always

A single portfolio number hides which assets carry the value. Ask for the components, because in most portfolios a small number of families account for nearly all of it.

What data exists

Available Not available
Academic value estimates Comprehensive transaction prices
Some disclosed licence terms Most licence terms — private
Litigation damages awards Settlement amounts — usually confidential
Brokered-deal reported pricing A complete market record
Maintenance fee behaviour Reasons for individual decisions

No public dataset contains patent sale prices at scale. Academic datasets such as KPSS provide value estimates derived from stock-market reactions at grant — modelled estimates rather than records of sales, since no transaction occurs and no price is paid.

Treating those as transaction prices is a common misreading, and it is worth asking any provider how they describe their sources. See intellectual property valuation.

Red flags in a valuation

Signal Meaning
No stated assumptions Cannot be checked
"Proprietary method" Cannot be interrogated
A single figure, no range Overstates precision
Status and ownership assumed May be valuing a dead patent
Cost approach used for a patent Wrong method
Sources described as transaction prices Frequently value estimates

A single number with no range overstates precision. The inputs are judgements, so the honest output is a range with the drivers identified.

Questions before commissioning

Ask Weak answer
What method, and why that one? "Proprietary"
Will you state the assumptions? Evasion
Do you verify status and ownership? "We use what you give us"
What data sources, and how described? Overstated
What standard is the report prepared to? None stated
Who signs it, and their qualifications? Unclear
What are the limitations? "None"

"Proprietary method" is the answer to be most cautious about. A valuation you cannot interrogate is a number you cannot defend in a negotiation, to a lender, or in a proceeding.

Purpose shapes method

Purpose Emphasis
Sale or purchase Market and income
Licensing negotiation Relief from royalty
Financing Realisable value, conservative
Litigation damages Statutory framework, not general valuation
Tax and accounting Standard-driven
Insolvency Liquidation basis

Damages are not a valuation exercise. They follow the statutory framework — reasonable royalty floor, lost profits above it, apportionment — which is a different analysis. See patent infringement damages.

What you can check yourself, free

Check Source Time
In force? USPTO Patent Center 3 min
Who owns it? USPTO Assignment Search 5 min
Remaining term, from the earliest parent Front page + family 5 min
Encumbrances recorded Assignment Search 5 min
Does anyone practise the claims? Product docs, competitor filings Hours
Ipiry Patent Survival Curve v1.0 Rate
Survive the 3.5-year fee (2022 cohort) 85.8%
Survive the 7.5-year fee (2018 cohort) 64.6%
Reach full term (2014 cohort) 41.4%
Abandoned before full term 58.6%

Computed from 27,273,654 USPTO maintenance fee records covering 8,262,336 US utility patents — see the patent survival curve.

Run these before commissioning anything. A valuation of a lapsed patent is a wasted fee, and checking takes minutes.

Patent valuation services: the checklist

  1. Prefer income methods. Cost tells you least about a patent.
  2. Demand stated assumptions — rate, base, discount rate, useful life.
  3. Treat "proprietary method" as a warning, not a reassurance.
  4. Confirm they verify status and ownership, or do it yourself first.
  5. Check the revenue base carefully. It moves the answer most.
  6. Subtract maintenance fees and annuities from any figure.
  7. Weight documented evidence of use above every other factor.
  8. Calculate remaining term from the earliest parent.
  9. Ask how sources are described. Value estimates are not sale prices.
  10. Match the method to the purpose. Damages follow a statutory framework instead.